Literature DB >> 29626598

EWSR1-NFATC2 gene fusion in a soft tissue tumor with epithelioid round cell morphology and abundant stroma: a case report and review of the literature.

Jarish N Cohen1, Amit J Sabnis2, Gregor Krings3, Soo-Jin Cho1, Andrew E Horvai1, Jessica L Davis4.   

Abstract

Mesenchymal round cell tumors are a diverse group of neoplasms defined by primitive, often high-grade cytomorphology. The most common molecular alterations detected in these tumors are gene rearrangements involving EWSR1 to one of many fusion partners. Rare EWSR1-NFATC2 gene rearrangements, corresponding to a t(20;22) gene translocation, have been described in mesenchymal tumors with clear round cell morphology and a predilection for the skeleton. We present a case of a tumor harboring the EWSR1-NFATC2 gene fusion arising in the subcutaneous tissue of a young woman. The tumor exhibited corded and trabecular architecture of epithelioid cells within abundant myxoid and fibrous stroma. The cells showed strong immunoreactivity for NKX2.2, variable CD99, keratin, and epithelial membrane antigen, but were negative for S100 and myoepithelial markers. Importantly, similar to previously reported cases, the clinical course was more indolent than that of Ewing sarcoma. This case highlights the distinctive clinicopathological characteristics of EWSR1-NFATC2 gene fusion-associated neoplasms that distinguish them from Ewing sarcoma.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone; EWSR1; Ewing sarcoma; Myoepithelial; NFATC2; Soft tissue

Mesh:

Substances:

Year:  2018        PMID: 29626598     DOI: 10.1016/j.humpath.2018.03.020

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

Review 1.  EWSR1/FUS-NFATc2 rearranged round cell sarcoma: clinicopathological series of 4 cases and literature review.

Authors:  Julio A Diaz-Perez; G Petur Nielsen; Cristina Antonescu; Martin S Taylor; Santiago A Lozano-Calderon; Andrew E Rosenberg
Journal:  Hum Pathol       Date:  2019-05-09       Impact factor: 3.466

Review 2.  Small round cell sarcomas.

Authors:  Florencia Cidre-Aranaz; Sarah Watson; James F Amatruda; Takuro Nakamura; Olivier Delattre; Enrique de Alava; Uta Dirksen; Thomas G P Grünewald
Journal:  Nat Rev Dis Primers       Date:  2022-10-06       Impact factor: 65.038

3.  NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma.

Authors:  Ken-Ichi Yoshida; Isidro Machado; Toru Motoi; Antonina Parafioriti; Maribel Lacambra; Hitoshi Ichikawa; Akira Kawai; Cristina R Antonescu; Akihiko Yoshida
Journal:  Am J Surg Pathol       Date:  2020-06       Impact factor: 6.394

4.  NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker.

Authors:  Raul Perret; Julien Escuriol; Valérie Velasco; Laetitia Mayeur; Isabelle Soubeyran; Christophe Delfour; Sébastien Aubert; Marc Polivka; Marie Karanian; Alexandra Meurgey; Sophie Le Guellec; Noelle Weingertner; Sylvia Hoeller; Jean-Michel Coindre; Frédérique Larousserie; Gaëlle Pierron; Franck Tirode; François Le Loarer
Journal:  Mod Pathol       Date:  2020-04-23       Impact factor: 7.842

5.  Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.

Authors:  Nathan D Seligson; Richard D Maradiaga; Colin M Stets; Howard M Katzenstein; Sherri Z Millis; Alan Rogers; John L Hays; James L Chen
Journal:  NPJ Precis Oncol       Date:  2021-05-21

Review 6.  An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.

Authors:  David S Shulman; Sarah B Whittle; Didier Surdez; Kelly M Bailey; Enrique de Álava; Jason T Yustein; Adam Shlien; Masanori Hayashi; Alexander J R Bishop; Brian D Crompton; Steven G DuBois; Neerav Shukla; Patrick J Leavey; Stephen L Lessnick; Heinrich Kovar; Olivier Delattre; Thomas G P Grünewald; Cristina R Antonescu; Ryan D Roberts; Jeffrey A Toretsky; Franck Tirode; Richard Gorlick; Katherine A Janeway; Damon Reed; Elizabeth R Lawlor; Patrick J Grohar
Journal:  NPJ Precis Oncol       Date:  2022-09-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.